The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

In animal studies, brain tumors nearly disappeared when an experimental drug, MT-125, was given as a combo with an oncology drug that otherwise does not work on aggressive glioblastoma. The U.S. Food ...

Bruce Leuchter, CEO, Neurvati, discusses the vital role of public participation in healthcare policy, highlighting how ...

Asked if he was going to deport Musk, a naturalized US citizen, Trump told reporters: 'I don't know. We'll have to take a look' ...

Food allergies affect up to 10% of the population in the USA and have been increasing in prevalence over the last 2–3 ...

The Oxfordshire, England-based mathematical modelling company said it has inked an 18-month contract worth GBP98,600 with an existing, unnamed client that will see it apply PK/PD modelling and ...

Enzyme Replacement Therapy for Pompe Disease Market to Reach $350 Million by 2025, Driven by Expanding Clinical Applications The global enzyme replacement therapy (ERT) targeting Pompe disease market ...

Once-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits ...